TTEC HOLDINGS INC (TTEC)
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for TTEC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TTEC | Director; Chair | 64 | ["Business Transformation Experience","Capital Markets or M&A Experience","Industry Experience","Operator or CEO Experience","Public Company Audit Experience","Public Company Board Experience","Risk Management Experience","Service Industry Experience","extensive experience in the healthcare industry","public company and private equity experience","operating partner for the healthcare group at Welsh, Carson, Anderson & Stowe","managing partner for Valtruis","served on the board of directors for Wayspring Health, Oncology Care Partners, and InterWell Health","president and CEO of OneOncology","executive vice president, health plans for CVS Health","special advisor to General Atlantic","held various senior executive positions at UnitedHealth Group and CIGNA Healthcare"] | ["Compensation","Executive","Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Tracy L. Bahl Age: 64 Director since 2013 TTEC Board Committees: Compensation (Chair) Executive Directorships: Andros Glooko, Inc. Past Directorships: MedExpress Gustavus Adolphus College Emdeon Mr. Bahl s extensive experience in the healthcare industry and his public company and private equity experience bring relevant and necessary skills, experience, and perspective to our Board. Since 2020, Mr. Bahl has served as an operating partner for the healthcare group at Welsh, Carson, Anderson & Stowe, a private equity firm specializing in healthcare and technology investments, and as a managing partner for Valtruis, and member of the board of directors for Wayspring Health, Oncology Care Partners, and InterWell Health, Valtruis portfolio companies. He also currently serves on the board of Glooko, a leading diabetes connected care company. Previously, Mr. Bahl served as the president and CEO of OneOncology, a General Atlantic portfolio company that provides administrative, operational, and scientific support to oncology practices throughout the U.S. Between 2013 and 2018, Mr. Bahl served as executive vice president, health plans for CVS Health. From 2007 to 2013, he served as a special advisor to General Atlantic, supporting various of its portfolio companies in leadership roles. Prior to 2007, Mr. Bahl held various senior executive positions as part of UnitedHealth Group and at CIGNA Healthcare.